// PL-002
GLP-3
GIP / GLP-1 / Glucagon Triple Agonist · MW ~4862 Da
Select Size
Research Effects
High-dose 30mg format of GLP-3, the triple incretin receptor agonist. Same pharmacology as 10mg, designed for extended research protocols.
- Triple receptor action: GLP-1R, GIPR, and glucagon receptor co-activation
- Larger volume for extended or multi-dose research protocols
- Dose-dependent weight reduction profile
- Hepatic fat reduction and insulin sensitivity improvement
- Suitable for longitudinal metabolic research studies
Include the compound name, size, quantity, and your shipping address. We reply within 24-48 hours.